Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.94
- Piotroski Score 3.00
- Grade Perform
- Symbol (OSH)
- Company Oak Street Health, Inc.
- Price $39.00
- Changes Percentage (0.08%)
- Change $0.03
- Day Low $38.98
- Day High $39.00
- Year High $39.00
Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 07/31/2023
- Fiscal Year End N/A
- Average Stock Price Target $39.00
- High Stock Price Target $79.00
- Low Stock Price Target $28.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.21
- Trailing P/E Ratio -17.647058823529
- Forward P/E Ratio -17.647058823529
- P/E Growth -17.647058823529
- Net Income $-509,700,000
Income Statement
Quarterly
Annual
Latest News of OSH
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Man undergoing electroshock treatment fights to end medical procedures
David Russell has been held at Regions Hospital on a court-ordered civil commitment, receiving 17 shock treatments at Mayo Clinic for mental illness. Doctors are petitioning for more treatments, but A...
By CBS News | 1 day ago -
Brinker International vs. Oshkosh: Buying on price momentum
Hennessy Funds Portfolio Manager Josh Wein analyzes Brinker International and Oshkosh stocks in the latest Good Buy or Goodbye episode....
By Yahoo! Finance | 1 day ago -
Joe Rogan and Josh Brolin rant about COVID-19 vaccine
Actor Josh Brolin shared his experience with Bell's palsy and discussed COVID-19 vaccines on The Joe Rogan Experience. Rogan raised concerns about vaccine side effects, while Brolin expressed worry ab...
By Newsweek | 1 day ago
